| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 3 |
| 1 | METHOTREXATE SODIUM | 3 |
| 2 | ADALIMUMAB | 2 |
| 3 | CYTARABINE | 2 |
| 4 | FINGOLIMOD HCL | 2 |
| 5 | LEVETIRACETAM | 2 |
| 6 | RITONAVIR | 2 |
| 7 | ABACAVIR | 1 |
| 8 | ABACAVIR SULFATE | 1 |
| 9 | AMLODIPINE BESYLATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 1 | 0.0019 |
| 1 | BETAINE | 1 | 0.0010 |
| 2 | BARICITINIB | 1 | 0.0003 |
| 3 | LEVOCARNITINE | 1 | 0.0003 |
| 4 | HYDROXOCOBALAMIN | 1 | 0.0002 |
| 5 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 1 | 0.0001 |
| 7 | CIMETIDINE | 1 | 0.0001 |
| 8 | ABACAVIR SULFATE | 1 | 0.0001 |
| 9 | PEGASPARGASE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Cytochrome P450 3A Inhibitor [EPC] | 3 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 3 |
| 2 | Protease Inhibitor [EPC] | 3 |
| 3 | Anti-epileptic Agent [EPC] | 2 |
| 4 | Atypical Antipsychotic [EPC] | 2 |
| 5 | Benzodiazepine [EPC] | 2 |
| 6 | Mood Stabilizer [EPC] | 2 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 8 | Alkylating Drug [EPC] | 1 |
| 9 | Antidote [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Methylating Agent [EPC] | 1 | 0.0010 |
| 2 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 3 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Methylxanthine [EPC] | 1 | 0.0000 |
| 8 | Antidote [EPC] | 1 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |